Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China

This order changes a prior rule about duty-free treatment for certain covered articles from the People's Republic of China. It says that duty-free "de minimis" treatment is available for otherwise eligible covered articles, but that it will stop being available after the Secretary of Commerce notifi